Chad Terhune's profile photo

Chad Terhune

Los Angeles

Health Reporter at Reuters

Health reporter @Reuters. Previously at WSJ, LA Times, KHN. @UFJSchool alum. Tips: [email protected] or DM for Signal (he/him)

Featured in: Favicon reuters.com (+1) Favicon apple.com Favicon cnn.com Favicon msn.com Favicon nytimes.com Favicon dailymail.co.uk Favicon wsj.com Favicon washingtonpost.com Favicon usatoday.com Favicon webmd.com

Articles

  • 2 days ago | timeslive.co.za | Chad Terhune |Robin Respaut

    04 June 2025 - 11:07 Just R20 for the first month. Support independent journalism by subscribing to our digital news package. The average rate of teens beginning treatment with the highly effective Novo Nordisk drug Wegovy grew 50% last year to 14.8 prescriptions per 100,000 adolescents, according to an analysis by health data firm Truveta. File photo.

  • 2 days ago | jp.reuters.com | Chad Terhune |Robin Respaut

    米国でデンマーク製薬大手ノボノルディスクの肥満症治療薬「ウゴービ」を使用する10代の若者が増加していることが、ヘルスケア情報会社トゥルベタの調査で分かった。写真はペンシルバニア州で2023年11月に撮影(2025年 ロイター/Hannah Beier) [ロサンゼルス 3日 ロイター] - 米国でデンマーク製薬大手ノボノルディスク(NOVOb.CO), opens new tabの肥満症治療薬「ウゴービ」を使用する10代の若者が増加していることが、ヘルスケア情報会社トゥルベタの調査で分かった。調査データをロイターが入手した。若者を対象とした同薬の使用に自信を持つ家族と医師が増えていることが背景にある。 データによると、ウゴービによる治療を始めた10代の若者の平均処方率は昨年は10万人当たり14.8件と前年の同9.9件から50%上昇した。今年1─3月の平均処方率は同17.3件でさらに上がっている。 それでもウゴービの処方を受けている若者は、10万人当たり2万3000人と推定される肥満症を患う10代の若者全体のごく一部に過ぎず、成人に比べると処方のペースははるかに遅い。...

  • 3 days ago | dagenspharma.dk | Chad Terhune |Robin Respaut

    Wegovy prescriptions for teens remain a small fraction of those with obesityInsurance hurdles limit use among doctors treating adolescentsExperts emphasize need for monitoring, lifestyle changes alongside GLP-1 medicationsLOS ANGELES, June 3 (Reuters) - American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with Reuters shows.

  • 3 days ago | reuters.com | Chad Terhune |Robin Respaut

    Wegovy presentation is displayed in New Columbia, Pennsylvania, U.S., November 13, 2023.

  • 3 days ago | today.westlaw.com | Robin Respaut |Chad Terhune |Bill Berkrot

    LOS ANGELES (Reuters) -American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with Reuters shows.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
10K
Tweets
37K
DMs Open
Yes
Chad Terhune
Chad Terhune @chadterhune
5 May 25

RT @latguild: Congratulations to @latimes columnist @GustavoArellano, a finalist for the 2024 @PulitzerPrizes for commentary! We are proud…

Chad Terhune
Chad Terhune @chadterhune
5 May 25

RT @kyoshino: Never in my wildest dreams did I think we’d be here today, three years in, winning a Pulitzer. My heart is full today. I am s…

Chad Terhune
Chad Terhune @chadterhune
5 May 25

RT @Reuters: BREAKING: Reuters has won the 2025 Pulitzer Prize in investigative reporting for a series of stories on the international trad…